Tag: LDL | Rare Disease Dialog Blog

Connect with NORD

Oct. 19, 2012

FDA advisory panel recommends approval of TWO new agents for HoFH

Posted at October 19, 2012 2:54 pm by E. Michael D. (Mike) Scott

In an extraordinary signal of the progress that is being made to find treatments for some types of rare disorders, an advisory committee to the U.S. Food and Drug Administration (FDA) has recommended approval this week for not just one but two new drugs to treat homozygous familial hypercholesterolemia (HoFH).

Twitter: RareDiseases

How do you use online communities? Check out new blog by Allie Freitas- disucsses @RareConnect! #raredisease http://t.co/dREPfjeHIw 02:11:17 PM May 13, 2013
#NORD salutes all mothers of children with #rarediseases today & every day! 12:52:57 PM May 12, 2013
Do you know who is performing at our annual gala next week? #NORD #raredisease http://t.co/kTpUyjfdVs 08:21:11 PM May 09, 2013
Thrilled to welcome more patient orgs to our family- Cutaneous Lymphoma Foundation & the Primary Ciliary Dyskinesia Foundation! 02:38:48 PM May 09, 2013
Congrats to #NORD Member Org- Sturge-Weber Foundation! Researchers identified genetic cause of syndrome! http://t.co/EJunYU5f9A … 02:38:02 PM May 09, 2013

@RareDiseases

Contact NORD	Featured Partnerships	Translate This page:
SUBSCRIBE TO OUR E-NEWS

	PATIENTS & MEMBERS
	RESEARCH
	ADVOCACY
	INDUSTRY
	MEDICAL
	FEATURED NEWS